Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England Journal of Medicine.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit future vaccines to older Americans and people at higher risk of serious ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Top officials for the FDA laid out new requirements limiting access to yearly COVID shots for healthy younger adults and ...

President Donald Trump said “I think we’re going to get everything we want” after a closed-door meeting with divided House ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

FDA Commissioner Marty Makary and Dr. Vinay Prasad outlined their booster shot clinical trial requirements in the New England Journal of Medicine.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...